Omeros Corporation
- OMER
- NASDAQ
- Biotechnology
- Inflammation/Rare Disease Treatments
$16.35
Today +0.93%Quote Oct 19, 2026, 08:00 PM UTC
−8.51%over the last month
Max drawdown −23.0%From 1-month high −22.3%3 months +71.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Omeros
Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
175
Market value
$1.18B
Quote Oct 19
Floor
$14.62
10.6% below price
Resistance
$16.52
1.0% above price
Price vs analyst targets
19 analysts
Lowest target
$22.00Highest target
$33.00
$22.00Highest target
$33.00
- Price $16.35
- Average target $27.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 68% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OMERPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free